These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1416826)

  • 1. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
    Hellinger WC; Rouse MS; Rabadan PM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1272-5. PubMed ID: 1416826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.
    Sullam PM; Täuber MG; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1985 Feb; 27(2):224-6. PubMed ID: 3920960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis.
    Fernández-Guerrero ML; Barros C; Rodriguez Tudela JL; Fernández Roblas R; Soriano F
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):525-7. PubMed ID: 3141162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM; Thauvin-Eliopoulos C; Moellering RC
    Clin Infect Dis; 1992 Jul; 15(1):58-62. PubMed ID: 1319757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    Vazquez J; Perri MB; Thal LA; Donabedian SA; Zervos MJ
    J Antimicrob Chemother; 1993 Nov; 32(5):715-21. PubMed ID: 8125836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose ampicillin for the treatment of high-level aminoglycoside resistant enterococcal endocarditis.
    Jones BL; Ludlam HA; Brown DF
    J Antimicrob Chemother; 1994 Apr; 33(4):891-2. PubMed ID: 8056716
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis.
    Aslangul E; Ruimy R; Chau F; Garry L; Andremont A; Fantin B
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4144-8. PubMed ID: 16189091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits.
    Fass RJ; Wright CA
    Antimicrob Agents Chemother; 1984 Apr; 25(4):408-10. PubMed ID: 6428306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.
    Lefort A; Arthur M; Garry L; Carbon C; Courvalin P; Fantin B
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2077-80. PubMed ID: 10898678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.